RMD FY 2023 Earnings Report — ResMed Inc. Revenue & Financial Results | Market Cap Arena

FY 2023 Earnings

Reported August 10, 2023

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2023	Prior Q	FY 2022	QoQ Change	YoY Change
Revenue	$4.2B	—	$3.6B	—	18.0%
Op. Income	$1.1B	—	$1.0B	—	13.2%
Gross Margin	55.8%	—	56.6%	—	-0.8pp
Net Margin	21.3%	—	21.8%	—	-0.5pp
EPS (Diluted)	$6.09	—	$5.30	—	14.9%
Free Cash Flow	$559M	—	$195M	—	186.7%

Revenue Flow

Item	Amount
REVENUE	$4.2B
Cost of Revenue	$1.9B
GROSS PROFIT	$2.4B
R&D Expenses	$288M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$874M
Other Expenses	$62M
Operating Expenses	$1.2B
Cost & Expenses	$3.1B
OPERATING INCOME	$1.1B
Interest Income	$0
Interest Expense	$47M
Other Income/Expenses	-$30M
INCOME BEFORE TAX	$1.1B
Income Tax Expense	$204M
Net Income from Continuing Ops	$898M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$898M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$898M
D&A	$197M
EBIT	$1.2B
EBITDA	$1.4B
EPS	$6
EPS Diluted	$6

Income Statement

Item	Amount
REVENUE	$4.2B
Cost of Revenue	$1.9B
GROSS PROFIT	$2.4B
R&D Expenses	$288M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$874M
Other Expenses	$62M
Operating Expenses	$1.2B
Cost & Expenses	$3.1B
OPERATING INCOME	$1.1B
Interest Income	$0
Interest Expense	$47M
Other Income/Expenses	-$30M
INCOME BEFORE TAX	$1.1B
Income Tax Expense	$204M
Net Income from Continuing Ops	$898M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$898M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$898M
D&A	$197M
EBIT	$1.2B
EBITDA	$1.4B
EPS	$6
EPS Diluted	$6

Cash Flow Statement

Item	Amount
Net Income	$898M
Depreciation & Amortization	$198M
Stock-Based Compensation	$71M
Deferred Income Tax	$216.0K
Other Non-Cash Items	-$11M
Change in Working Capital	-$462M
OPERATING CASH FLOW	$693M
Capital Expenditure	-$134M
Acquisitions (Net)	-$1.0B
Purchases of Investments	-$32M
Sales/Maturities of Investments	$4M
Other Investing Activities	$15M
NET CASH FROM INVESTING	-$1.2B
Net Debt Issuance	$665M
Common Stock Repurchased	$0
Common Dividends Paid	-$258M
Other Financing Activities	-$33M
NET CASH FROM FINANCING	$423M
FREE CASH FLOW	$559M
Net Change in Cash	-$46M

Balance Sheet

Item	Amount
Cash & Equivalents	$228M
Short-Term Investments	$0
Net Receivables	$705M
Inventory	$998M
Other Current Assets	$180M
TOTAL CURRENT ASSETS	$2.4B
PP&E (Net)	$666M
Goodwill	$2.8B
Intangible Assets	$552M
Long-Term Investments	$157M
Tax Assets	$133M
Other Non-Current Assets	$106M
TOTAL NON-CURRENT ASSETS	$4.4B
TOTAL ASSETS	$6.8B
Account Payables	$151M
Short-Term Debt	$10M
Deferred Revenue	$138M
Other Current Liabilities	$10M
TOTAL CURRENT LIABILITIES	$759M
Long-Term Debt	$1.4B
Deferred Revenue NC	$119M
Deferred Tax Liabilities	$91M
Other Non-Current Liabilities	$105M
TOTAL NON-CURRENT LIABILITIES	$1.9B
TOTAL LIABILITIES	$2.6B
Common Stock	$588.0K
Additional Paid-In Capital	$1.8B
Retained Earnings	$4.3B
Treasury Stock	-$1.6B
Accum. Other Comp. Income	-$273M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$4.1B
Minority Interest	$0
TOTAL EQUITY	$4.1B
TOTAL LIABILITIES & EQUITY	$6.8B
Total Debt	$1.6B
Net Debt	$1.4B